Sepsis, Severe clinical trials at UCSF

1 research study open to eligible people

Severe sepsis is a medical emergency when infection causes organs to stop working. UCSF is tracking transposable element levels in patient blood and recording clinical outcomes in an observational study. UCSF is also running studies of immune tests and treatment effects in severe sepsis.

Showing trials for

  • Role of Transposable Elements in Septic Immune Aging

    open to eligible people ages 18 years and up

    The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: 1. Do transposable elements prematurely age the immune systems of patients with sepsis? 2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU? 3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU? Participants will have blood drawn from them but will not be subjected to additional interventions.

    San Francisco, California

Our lead scientists for Sepsis, Severe research studies include .

Last updated: